SCHAAN, Liechtenstein: The Ivoclar Group, a leading manufacturer of integrated solutions for high-quality dental care, has published the fourth volume of the IPS e.max Scientific Report. Offering a concise overview of the clinical performance of the ceramic material family, the report summarises more than 20 international studies and confirms documented survival rates of over 95%.